Payden & Rygel’s Thermo Fisher Scientific TMO Stock Holding History

Payden & Rygel’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.06M	Buy	+16,400	New	+$8.9M	0.62%	64
2024 Q4	–	Sell	-1,800	Closed	-$1.11M	–	133
2024 Q3	$1.11M	Hold	1,800	–	–	0.09%	84
2024 Q2	$995K	Sell	1,800 -1,100	-38%	-$630K	0.08%	84
2024 Q1	$1.69M	Hold	2,900	–	–	0.08%	88
2023 Q4	$1.54M	Hold	2,900	–	–	0.11%	88
2023 Q3	$1.47M	Sell	2,900 -600	-17%	-$320K	0.1%	91
2023 Q2	$1.83M	Sell	3,500 -2,000	-36%	-$1.08M	0.13%	94
2023 Q1	$3.17M	Hold	5,500	–	–	0.19%	85
2022 Q4	$3.03M	Hold	5,500	–	–	0.16%	81
2022 Q3	$2.79M	Buy	5,500 +2,000	+57%	+$1.12M	0.16%	81
2022 Q2	$1.9M	Buy	+3,500	New	+$1.93M	0.11%	82
2021 Q1	–	Sell	-700	Closed	-$326K	–	149
2020 Q4	$326K	Hold	700	–	–	0.02%	94
2020 Q3	$309K	Hold	700	–	–	0.02%	87
2020 Q2	$254K	Hold	700	–	–	0.02%	82
2020 Q1	$199K	Hold	700	–	–	0.01%	81
2019 Q4	$227K	Hold	700	–	–	0.01%	84
2019 Q3	$204K	Hold	700	–	–	0.01%	79
2019 Q2	$206K	Hold	700	–	–	0.01%	84
2019 Q1	$192K	Hold	700	–	–	0.01%	86
2018 Q4	$157K	Hold	700	–	–	0.01%	86
2018 Q3	$171K	Hold	700	–	–	0.01%	84
2018 Q2	$145K	Hold	700	–	–	0.01%	86
2018 Q1	$145K	Hold	700	–	–	0.01%	87
2017 Q4	$133K	Hold	700	–	–	0.01%	91
2017 Q3	$132K	Hold	700	–	–	0.01%	90
2017 Q2	$122K	Hold	700	–	–	0.01%	80
2017 Q1	$108K	Hold	700	–	–	0.01%	83
2016 Q4	$99K	Hold	700	–	–	0.01%	86
2016 Q3	$111K	Hold	700	–	–	0.01%	76
2016 Q2	$103K	Hold	700	–	–	0.01%	79
2016 Q1	$99K	Sell	700 -74	-10%	-$9.92K	0.01%	81
2015 Q4	$110K	Buy	774 +74	+11%	+$9.87K	0.01%	86
2015 Q3	$86K	Hold	700	–	–	0.01%	94
2015 Q2	$91K	Hold	700	–	–	0.01%	96
2015 Q1	$94K	Hold	700	–	–	0.01%	100
2014 Q4	$88K	Hold	700	–	–	0.02%	94
2014 Q3	$85K	Hold	700	–	–	0.02%	98
2014 Q2	$83K	Hold	700	–	–	0.02%	102
2014 Q1	$84K	Hold	700	–	–	0.03%	95
2013 Q4	$78K	Hold	700	–	–	0.03%	134
2013 Q3	$65K	Hold	700	–	–	0.02%	128
2013 Q2	$59K	Buy	+700	New	+$58.3K	0.02%	129

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Payden & Rygel's TMO Position: Q1 2026 in Review

Payden & Rygel opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 16,400 shares worth $8.06M. The stake represents 0.62% of the portfolio and ranks #64 among its holdings. This is a return to the name: Payden & Rygel previously reported a position in TMO as recently as Q3 2024.

Payden & Rygel first reported a position in TMO in Q2 2013 and has held it in 42 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Payden & Rygel held 16,400 shares of Thermo Fisher Scientific worth $8.06M as of Q1 2026.
Thermo Fisher Scientific was a new Payden & Rygel position in Q1 2026.
Thermo Fisher Scientific made up 0.62% of Payden & Rygel's portfolio in Q1 2026, its #64 holding.
Payden & Rygel first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 42 quarters since.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.